genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2014
Drug licensing
News
Celgene to Develop Nogra Crohn’s Drug for Up to $2.6B
News
BioAlliance Licenses Herpes Treatment to Innocutis
Cancer
PharmEssentia Licenses Kinex Oncology Drugs
News
Novartis Eyes Conditional Serelaxin OK after European Setback
News
Coming Sooner: Generic Viagra’s U.S. Launch Set for 2017 as Teva, Pfizer Settle Lawsuit
News
Melior Licenses Insulin Sensitizer to Bukwang
News
Auxilium Licenses Stendra from Vivus for Up to $300M
Insights
Prepping for the Clinic
Drug Discovery
Allergan Licenses Rights to Medytox Candidates, in Up-to-$362M Deal
News
AstraZeneca Licenses 3 X-Chem Drug Discovery Programs
1
...
3
4
5
...
18
Page 4 of 18
Scroll Up
Scroll Up
